G. E. H. M. Rutten Et Al. , "LEADER 7: cardiovascular risk profiles of US and European participants in the LEADER diabetes trial differ," DIABETOLOGY & METABOLIC SYNDROME , vol.8, 2016
Rutten, G. E. H. M. Et Al. 2016. LEADER 7: cardiovascular risk profiles of US and European participants in the LEADER diabetes trial differ. DIABETOLOGY & METABOLIC SYNDROME , vol.8 .
Rutten, G. E. H. M., Tack, C. J., Pieber, T. R., ÇÖMLEKÇİ, A., Orsted, D. D., Baeres, F. M. M., ... Marso, S. P.(2016). LEADER 7: cardiovascular risk profiles of US and European participants in the LEADER diabetes trial differ. DIABETOLOGY & METABOLIC SYNDROME , vol.8.
Rutten, Guy Et Al. "LEADER 7: cardiovascular risk profiles of US and European participants in the LEADER diabetes trial differ," DIABETOLOGY & METABOLIC SYNDROME , vol.8, 2016
Rutten, Guy E. Et Al. "LEADER 7: cardiovascular risk profiles of US and European participants in the LEADER diabetes trial differ." DIABETOLOGY & METABOLIC SYNDROME , vol.8, 2016
Rutten, G. E. H. M. Et Al. (2016) . "LEADER 7: cardiovascular risk profiles of US and European participants in the LEADER diabetes trial differ." DIABETOLOGY & METABOLIC SYNDROME , vol.8.
@article{article, author={Guy E. H. M. Rutten Et Al. }, title={LEADER 7: cardiovascular risk profiles of US and European participants in the LEADER diabetes trial differ}, journal={DIABETOLOGY & METABOLIC SYNDROME}, year=2016}